{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:23:09Z","timestamp":1772785389947,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.parint.2017.04.004","type":"journal-article","created":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T16:45:54Z","timestamp":1491842754000},"page":"545-554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma \u2013induced liver fibrosis"],"prefix":"10.1016","volume":"66","author":[{"given":"Abeer A.","family":"Elhenawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehab H.","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nairmen","family":"Nabih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa M.","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmeen","family":"Megahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parint.2017.04.004_bb0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1756-3305-3-60","article-title":"Hepatic stellate cells and parasite-induced liver fibrosis","volume":"3","author":"Anthony","year":"2010","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.parint.2017.04.004_bb0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1476-072X-11-51","article-title":"Schistosomiasis transmission and environmental change: A spatio-temporal analysis in Porto de Galinhas, Pernambuco-Brazil","volume":"11","author":"Gomes","year":"2012","journal-title":"Int. J. Health Geogr."},{"key":"10.1016\/j.parint.2017.04.004_bb0015","first-page":"21","article-title":"Schistosomiasis: number of people receiving preventive chemotherapy in 2012","volume":"89","author":"World Health Organization","year":"2014","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.parint.2017.04.004_bb0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-3024.2009.01157.x","article-title":"Schistosomiasis and liver fibrosis","volume":"31","author":"Andrade","year":"2009","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.parint.2017.04.004_bb0025","first-page":"76","article-title":"Modern pathogenetic concepts of liver fibrosis suggests stellate cells and TGF-\u03b2 as major players and therapeutic targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J. Cell Biol. Med."},{"key":"10.1016\/j.parint.2017.04.004_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1590\/S0074-02761987000800010","article-title":"Cell-matrix interactions in schistosomal portal fibrosis: adynamic event","volume":"82","author":"Grimaud","year":"1987","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.parint.2017.04.004_bb0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.parint.2017.04.004_bb0040","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.parint.2017.04.004_bb0045","doi-asserted-by":"crossref","first-page":"G1093","DOI":"10.1152\/ajpgi.00292.2009","article-title":"Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis","volume":"297","author":"Choi","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.parint.2017.04.004_bb0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrm1622","article-title":"Communicating with Hedgehogs","volume":"6","author":"Hooper","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.parint.2017.04.004_bb0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2007.07.032","article-title":"Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells","volume":"48","author":"Yang","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.parint.2017.04.004_bb0060","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2010.10.003","article-title":"Hedgehog signaling in the liver","volume":"54","author":"Omenetti","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.parint.2017.04.004_bb0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/liv.12016","article-title":"Macrophage-derived hedgehog ligands promotes fibrogenic and angiogenic responses in human schistosomiasis mansoni","volume":"33","author":"Pereira","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.parint.2017.04.004_bb0070","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1016\/j.bmcl.2009.08.049","article-title":"GDC-0449-a potent inhibitor of the hedgehog pathway","volume":"19","author":"Robarge","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.parint.2017.04.004_bb0075","doi-asserted-by":"crossref","first-page":"e23943","DOI":"10.1371\/journal.pone.0023943","article-title":"Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer","volume":"6","author":"Philips","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.parint.2017.04.004_bb0080","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2307\/3277297","article-title":"A rapid method of infecting mice and other laboratory animals with Schistosoma mansoni by subcutaneous injection","volume":"55","author":"Peters","year":"1969","journal-title":"J. Parasitol."},{"key":"10.1016\/j.parint.2017.04.004_bb0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.parint.2017.04.004_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00389899","article-title":"Praziquantel, a new broad spectrum antischistosomal agent","volume":"52","author":"Gonnert","year":"1977","journal-title":"Z. Parasitenkd"},{"key":"10.1016\/j.parint.2017.04.004_bb0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4269\/ajtmh.1962.11.201","article-title":"New approach to the screening of drugs in experimental schistosomiasis mansoni in mice","volume":"11","author":"Pellegrino","year":"1962","journal-title":"Am.J.Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2017.04.004_bb0100","first-page":"328","article-title":"Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues","volume":"39","author":"Cheever","year":"1968","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.parint.2017.04.004_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajcp\/28.1.56","article-title":"A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases","volume":"28","author":"Reitman","year":"1957","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.parint.2017.04.004_bb0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0009-9120(96)00003-6","article-title":"A simplified method for the analysis of hydroxyproline in biological tissues","volume":"29","author":"Reddy","year":"1996","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.parint.2017.04.004_bb0115","first-page":"711","article-title":"Host response to eggs of S. mansoni. I. Granuloma formation in the unsensitized laboratory mouse","volume":"41","author":"Lichtenberg","year":"1962","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.parint.2017.04.004_bb0120","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.parint.2017.04.004_bb0125","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/00007890-199306000-00011","article-title":"Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine","volume":"55","author":"Suzuki","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.parint.2017.04.004_bb0130","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1017\/S0031182000086248","article-title":"The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms","volume":"55","author":"Smithers","year":"1965","journal-title":"Parasitology"},{"key":"10.1016\/j.parint.2017.04.004_bb0135","series-title":"Encyclopedia of Measurement and Statistics","first-page":"1","article-title":"Bonferroni and Sidak corrections for multiple comparisons","author":"Abdi","year":"2007"},{"key":"10.1016\/j.parint.2017.04.004_bb0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1590\/S0074-02761998000700004","article-title":"Role of cytokines in the formation and downregulation of hepatic circumoval granulomas and hepatic fibrosis in Schistosoma mansoni-infected mice","volume":"93","author":"Cheever","year":"1998","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.parint.2017.04.004_bb0145","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1600-0463.2010.02645.x","article-title":"Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: Parasitological, biochemical and immunohistochemical assessment","volume":"118","author":"Botros","year":"2010","journal-title":"APMIS"},{"key":"10.1016\/j.parint.2017.04.004_bb0150","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1590\/S0074-02761997000500025","article-title":"Impact of antifibrotic treatment on the course of Schistosoma mansoni infection in murine model","volume":"92","author":"Giboda","year":"1997","journal-title":"Mem. Inst. Oswaldo Cruz. Rio de Janeiro"},{"key":"10.1016\/j.parint.2017.04.004_bb0155","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00436-011-2485-2","article-title":"Effect of praziquantel prolonged administration on granuloma formation around Schistosoma japonicum eggs in lung of sensitized mice","volume":"109","author":"Huang","year":"2011","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.parint.2017.04.004_bb0160","doi-asserted-by":"crossref","first-page":"e20247","DOI":"10.1371\/journal.pone.0020247","article-title":"New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum","volume":"6","author":"Liang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.parint.2017.04.004_bb0165","first-page":"42","article-title":"Efficacy of praziquantel in school-aged children in a hyperendemic zone for Schistosoma haematobium (Niger, 1999)","volume":"94","author":"Garba","year":"2001","journal-title":"B. Soc. Pathol. Exot."},{"key":"10.1016\/j.parint.2017.04.004_bb0170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1574-695X.2009.00640.x","article-title":"Factors controlling the effect of praziquantel on liver fibrosis in Schistosoma mansoni-infected patients","volume":"58","author":"Rahoud","year":"2010","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.parint.2017.04.004_bb0175","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1478-3231.2007.01463.x","article-title":"Antioxidant and hepatoprotective effects of Ginkgo biloba phytosomes in carbon tetrachloride-induced liver injury in rodents","volume":"27","author":"Naik","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.parint.2017.04.004_bb0180","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0035-9203(84)90206-2","article-title":"The immunological aspects of praziquantel in unsensitized mice with experimentally induced schistosome pulmonary granuloma","volume":"78","author":"Botros","year":"1984","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2017.04.004_bb0185","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4049\/jimmunol.153.2.753","article-title":"Anti IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis","volume":"153","author":"Cheever","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.parint.2017.04.004_bb0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.fct.2013.02.033","article-title":"Platycodi Radix attenuates dimethylnitrosamine-induced liver fibrosis in rats by inducing Nrf2-mediated antioxidant enzymes","volume":"56","author":"Choi","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.parint.2017.04.004_bb0195","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2334-5-45","article-title":"The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis","volume":"5","author":"Chatterjee","year":"2005","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.parint.2017.04.004_bb0200","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.jas.2011.07.022","article-title":"Fish bone chemistry and ultrastructure: Implications for taphonomy and stable isotope analysis","volume":"38","author":"Szpak","year":"2011","journal-title":"J. Archaeol. Sci."},{"key":"10.1016\/j.parint.2017.04.004_bb0205","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/hep.25559","article-title":"Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease","volume":"55","author":"Guy","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.parint.2017.04.004_bb0210","doi-asserted-by":"crossref","first-page":"e74141","DOI":"10.1371\/journal.pone.0074141","article-title":"Potential role of hedgehog pathway in liver response to radiation","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.parint.2017.04.004_bb0215","doi-asserted-by":"crossref","first-page":"206(8)","DOI":"10.1007\/s00534-012-0576-9","article-title":"Activation of alpha-smooth muscle actin-positive myofibroblast-like cells after chemotherapy with gemcitabine in a rat orthotopic pancreatic cancer model (Report)","volume":"20","author":"Yamao","year":"2013","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"10.1016\/j.parint.2017.04.004_bb0220","first-page":"3331","article-title":"Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans","volume":"118","author":"Omenetti","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.parint.2017.04.004_bb0225","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.23019","article-title":"Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production","volume":"50","author":"Omenetti","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.parint.2017.04.004_bb0230","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMoa0902903","article-title":"Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449","volume":"361","author":"Rudin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parint.2017.04.004_bb0235","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJMoa0905360","article-title":"Inhibition of the hedgehog pathway in advanced basal-cell carcinoma","volume":"361","author":"Von Hoff","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parint.2017.04.004_bb0240","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1124\/dmd.111.039339","article-title":"A single dose mass balance study of the hedgehog pathway inhibitor Vismodegib (GDC-0449) in humans using accelerator mass spectrometry","volume":"39","author":"Graham","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.parint.2017.04.004_bb0245","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1158\/1078-0432.CCR-10-2745","article-title":"Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors","volume":"17","author":"LoRusso","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.parint.2017.04.004_bb0250","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3109\/00498250903180289","article-title":"Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl) phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic hedgehog signalling pathway inhibitor","volume":"39","author":"Wong","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.parint.2017.04.004_bb0255","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1158\/1078-0432.CCR-11-0975","article-title":"Pharmacokinetic\u2013pharmacodynamic analysis of Vismodegib in preclinical models of mutational and ligand-dependent hedgehog pathway activation","volume":"17","author":"Wong","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.parint.2017.04.004_bb0260","doi-asserted-by":"crossref","first-page":"e27306","DOI":"10.1371\/journal.pone.0027306","article-title":"Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: Molecular mechanisms","volume":"6","author":"Singh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.parint.2017.04.004_bb0265","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3109\/1061186X.2012.719900","article-title":"Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling","volume":"20","author":"Pratap","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.parint.2017.04.004_bb0270","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/QCO.0b013e328318978f","article-title":"Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis","volume":"21","author":"Doenhoff","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.parint.2017.04.004_bb0275","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0001-706X(03)00031-7","article-title":"Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics","volume":"86","author":"Dayan","year":"2003","journal-title":"Acta Trop."},{"key":"10.1016\/j.parint.2017.04.004_bb0280","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0976-500X.107628","article-title":"The dawn of hedgehog inhibitors: Vismodegib","volume":"4","author":"Sandhiya","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.parint.2017.04.004_bb0285","first-page":"573","article-title":"Halofuginone as an antifibrotic therapy in chronic schistosomal liver fibrosis in mice","volume":"16","author":"Deyab","year":"2007","journal-title":"Egypt. J. Med. Microbiol."},{"key":"10.1016\/j.parint.2017.04.004_bb0290","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1756-3305-5-9","article-title":"Anti-inflammatory\/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis","volume":"5","author":"El-Lakkany","year":"2012","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.parint.2017.04.004_bb0295","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00436-010-2014-8","article-title":"Silymarin treatment reduces granuloma and hepatic fibrosis in experimental schistosomiasis","volume":"107","author":"Mata-Santos","year":"2010","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.parint.2017.04.004_bb0300","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1128\/AAC.01936-13","article-title":"Silymarin reduces profibrogenic cytokines and reverses hepatic fibrosis in chronic murine schistosomiasis","volume":"58","author":"Mata-Santos","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2017.04.004_bb0305","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1017\/S0031182000053920","article-title":"Schistosoma mansoni: structural damage and tegumental repair after in vivo treatment with praziquantel","volume":"94","author":"Shaw","year":"1987","journal-title":"Parasitology"},{"key":"10.1016\/j.parint.2017.04.004_bb0310","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-3024.1990.tb00958.x","article-title":"Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worms exposed to praziquantel and immune serum in vivo","volume":"12","author":"Modha","year":"1990","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.parint.2017.04.004_bb0315","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1590\/S0074-02762002000500023","article-title":"Ultrastructural alterations in adult Schistosoma mansoni caused by artemether","volume":"97","author":"Xiao","year":"2002","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.parint.2017.04.004_bb0320","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1590\/S0037-86822011005000023","article-title":"Ultrastructural study on the morphological changes to male worms of Schistosoma mansoni after in vitro exposure to allicin","volume":"44","author":"Lima","year":"2011","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.parint.2017.04.004_bb0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-4894(88)90104-X","article-title":"Schistosoma mansoni: praziquantel-induced changes to the female reproductive system","volume":"65","author":"Shaw","year":"1988","journal-title":"Exp. Parasitol."}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576916302537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576916302537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T02:37:21Z","timestamp":1692758241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576916302537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1383576916302537"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2017.04.004","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma\u2013induced liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2017.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}